at Zacks.com (Thu, 5:20PM)
Baxter International (BAX -0.5%) says the results from two large, international multicenter trials it conducted show that a low glucose peritoneal dialysis regimen favorably impacted metabolic measures important for end-stage renal disease patients with diabetes, including blood glucose control and selected lipids. The combined results were presented at the 49th Annual European Renal Association - European Dialysis and Transplant Association congress in Paris.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Zacks.com (Thu, 8:47AM)
at Zacks.com (Tue, 3:45PM)
at Zacks.com (Jan 21, 2015)
at Investor's Business Daily (Jan 16, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs